Adjuvant therapies for HIV-associated neurocognitive disorders

Rivastigmine for HIV-associated neurocognitive disorders: A randomized crossover pilot study

(2013) S. Simioni et al.   NEUROLOGY

Assessment, Diagnosis, and Treatment of HIV-Associated Neurocognitive Disorder: A Consensus Report of the Mind Exchange Program

(2012) et al.   CLINICAL INFECTIOUS DISEASES

Randomized trial of minocycline in the treatment of HIV-associated cognitive impairment

(2012) N. Nakasujja et al.   NEUROLOGY

CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy

(2011) Ronald J. Ellis et al.   AIDS

Screening for Cognitive Impairment in Human Immunodeficiency Virus

(2011) V. Valcour et al.   CLINICAL INFECTIOUS DISEASES

HIV-Associated Neurological Disorders

(2011) Ik L. Tan et al.   CNS DRUGS

Minocycline treatment for HIV-associated cognitive impairment: Results from a randomized trial

(2011) N. Sacktor et al.   NEUROLOGY

HIV-associated neurocognitive disorders: is there a hidden epidemic?

(2010) Justin C McArthur et al.   AIDS

Memantine for AIDS Dementia Complex: Open-Label Report of ACTG 301

(2010) Yu Zhao et al.   HIV CLINICAL TRIALS

HIV-Associated Neurocognitive Disorder: Pathogenesis and Therapeutic Opportunities

(2010) Kathryn A. Lindl et al.   Journal of Neuroimmune Pharmacology

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

(2010) R. K. Heaton et al.   NEUROLOGY

Lithium therapy for human immunodeficiency virus type 1–associated neurocognitive impairment

(2009) Giovanni Schifitto et al.   JOURNAL OF NEUROVIROLOGY

Selegiline and oxidative stress in HIV-associated cognitive impairment

(2009) G. Schifitto et al.   NEUROLOGY